Related Experiment Videos
Multiple blood transfusions reduce the recurrence rate of Crohn's disease
W R Peters1, R D Fry, J W Fleshman
1Department of Surgery, Jewish Hospital of St. Louis, Washington University Medical Center, Missouri.
Insights
Perioperative blood transfusions may reduce Crohn's disease recurrence after intestinal resection. Patients receiving multiple transfusions showed a lower recurrence rate, suggesting a potential immunosuppressive effect of blood.
Area of Science:
- Gastroenterology
- Immunology
- Surgical Oncology
Background:
- Crohn's disease recurrence post-resection is a significant clinical concern.
- The impact of perioperative blood transfusions on Crohn's disease outcomes remains incompletely understood.
Purpose of the Study:
- To investigate the association between perioperative red blood cell transfusions and the recurrence rate of Crohn's disease following initial intestinal resection.
Main Methods:
- Retrospective review of 79 patients undergoing initial intestinal resection for Crohn's disease.
- Analysis of recurrence rates based on transfusion status (multiple transfusions vs. none) using Kaplan-Meier survival analysis.
- Stratification of recurrence by disease location (small bowel, colon, ileocolic).
Main Results:
- Patients receiving multiple perioperative transfusions had a significantly lower recurrence rate (22%) by 36 months compared to non-transfused patients (44%) (P < 0.04).
- The median time to recurrence was longer in the multiply transfused group (35 months) versus the non-transfused group (20 months).
- A trend towards decreased recurrence was observed in multiply transfused patients with ileocolic disease (10% vs. 45%, P = 0.057).
Conclusions:
- Multiple perioperative blood transfusions may be associated with a reduced risk of Crohn's disease recurrence after intestinal resection.
- This finding suggests a potential role for transfusion-induced immunosuppression in modulating disease activity.
- Further research is warranted to elucidate the mechanisms and clinical implications of this observation.
Abstract:
In order to determine whether perioperative blood transfusion affects the recurrence of Crohn's disease, the authors reviewed the records of 79 patients with Crohn's disease who underwent their initial intestinal resection at their institution. Recurrence of Crohn's disease was documented by radiographic studies, endoscopy, or laparotomy. During the hospital admission for resection, 45 patients received multiple red blood cell transfusions. Recurrence developed in 22 percent of these patients by 36 months, and the median time to recurrence was 35 months. In the 34 patients who did not receive multiple transfusions, recurrence was found in 44 percent by 36 months, and the median time to recurrence was 20 months. These differences are significant, using the Kaplan-Meier analysis (P less than 0.04). Recurrence in patients with disease limited to the small bowel or to the colon was not significantly affected by the transfusion status. However, recurrence developed in only 10 percent of multiply transfused patients with ileocolic disease by 36 months, whereas recurrence developed in 45 percent of the patients who were not multiply transfused. (Significance, P = 0.057). The authors believe that the observed decreased rate of recurrence of Crohn's disease in patients receiving multiple perioperative transfusions may represent another example of clinically significant immunosuppression from blood transfusion.